New acting deputy CDER promotion elevates longtime GLP-1 reviewer
Acting FDA CDER director Michael Davis has promoted Lisa Yanoff, a longtime FDA staffer, as an acting deputy director at the drug center. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The…
Acting FDA CDER director Michael Davis has promoted a longtime FDA staffer as an acting deputy director at the drug center.
Lisa Yanoff, an agency veteran with expertise in metabolic drug reviews, is taking over ...
Source: Endpoints News